Shi Qing-Qiang, Zuo Guo-Wei, Feng Zi-Qiang, Zhao Lv-Cui, Luo Lian, You Zhi-Mei, Li Dang-Yang, Xia Jing, Li Jing, Chen Di-Long
Laboratory of Stem Cell and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University, Chongqing, China E-mail :
Asian Pac J Cancer Prev. 2014;15(18):7849-55. doi: 10.7314/apjcp.2014.15.18.7849.
To investigate the effect of deacetylase inhibitory trichostatin A (TSA) on anti HepG2 liver carcinoma cells and explore the underlying mechanisms.
HepG2 cells exposed to different concentrations of TSA for 24, 48, or 72h were examined for cell growth inhibition using CCK8, changes in cell cycle distribution with flow cytometry, cell apoptosis with annexin V-FTIC/PI double staining, and cell morphology changes under an inverted microscope. Expression of β-catenin, HDAC1, HDAC3, H3K9, CyclinD1 and Bax proteins was tested by Western blotting. Gene expression for β-catenin, HDAC1and HDAC3 was tested by q-PCR. β-Catenin and H3K9 proteins were also tested by immunofluorescence. Activity of Renilla luciferase (pTCF/LEF-luc) was assessed using the Luciferase Reporter Assay system reagent. The activity of total HDACs was detected with a HDACs colorimetric kit.
Exposure to TSA caused significant dose-and time-dependent inhibition of HepG2 cell proliferation (p<0.05) and resulted in increased cell percentages in G0/ G1 and G2/M phases and decrease in the S phase. The apoptotic index in the control group was 6.22±0.25%, which increased to 7.17±0.20% and 18.1±0.42% in the treatment group. Exposure to 250 and 500nmol/L TSA also caused cell morphology changes with numerous floating cells. Expression of β-catenin, H3K9and Bax proteins was significantly increased, expression levels of CyclinD1, HDAC1, HDAC3 were decreased. Expression of β-catenin at the genetic level was significantly increased, with no significant difference in HDAC1and HDAC3 genes. In the cytoplasm, expression of β-catenin fluorescence protein was not obvious changed and in the nucleus, small amounts of green fluorescence were observed. H3K9 fluorescence protein were increased. Expression levels of the transcription factor TCF werealso increased in HepG2 cells following induction by TSA, whikle the activity of total HDACs was decreased.
TSA inhibits HDAC activity, promotes histone acetylation, and activates Wnt/β-catenin signaling to inhibit proliferation of HepG2 cell, arrest cell cycling and induce apoptosis.
研究去乙酰化酶抑制剂曲古抑菌素A(TSA)对人肝癌HepG2细胞的作用,并探讨其潜在机制。
将HepG2细胞暴露于不同浓度的TSA中24、48或72小时,采用CCK8法检测细胞生长抑制情况,流式细胞术检测细胞周期分布变化,膜联蛋白V-FTIC/PI双染法检测细胞凋亡情况,倒置显微镜下观察细胞形态变化。采用蛋白质免疫印迹法检测β-连环蛋白、组蛋白去乙酰化酶1(HDAC1)、组蛋白去乙酰化酶3(HDAC3)、组蛋白H3第9位赖氨酸(H3K9)、细胞周期蛋白D1(CyclinD1)和凋亡蛋白Bax的表达。采用实时荧光定量聚合酶链反应(q-PCR)检测β-连环蛋白、HDAC1和HDAC3的基因表达。采用免疫荧光法检测β-连环蛋白和H3K9蛋白。使用荧光素酶报告基因检测系统试剂评估海肾荧光素酶(pTCF/LEF-luc)的活性。用HDACs比色试剂盒检测总HDACs的活性。
TSA处理可引起HepG2细胞增殖的剂量和时间依赖性显著抑制(p<0.05),导致G0/G1期和G2/M期细胞百分比增加,S期细胞百分比降低。对照组凋亡指数为6.22±0.25%,处理组分别增至7.17±0.20%和18.1±0.42%。暴露于250和500nmol/L TSA还导致细胞形态改变,出现大量漂浮细胞。β-连环蛋白、H3K9和Bax蛋白表达显著增加,CyclinD1、HDAC1、HDAC3表达水平降低。β-连环蛋白基因水平表达显著增加,HDAC1和HDAC3基因无显著差异。在细胞质中,β-连环蛋白荧光蛋白表达无明显变化,在细胞核中观察到少量绿色荧光。H3K9荧光蛋白增加。TSA诱导后,HepG2细胞中转录因子TCF的表达水平也增加,而总HDACs的活性降低。
TSA抑制HDAC活性,促进组蛋白乙酰化,激活Wnt/β-连环蛋白信号通路,从而抑制HepG2细胞增殖,使细胞周期停滞并诱导凋亡。